Saturday 17 October 2026 Export AQST’s income statement to Excel — free account

Aquestive Therapeutics, Inc.

AQST Healthcare Drug Manufacturers Specialty & Generic

Aquestive Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.5 million, down 22.6% from fiscal 2024. In the quarter to June 2026, revenue grew 38.2%, EPS fell 28.6%, free cash flow fell 20.4% and total debt rose 59.1%, each against the same quarter a year earlier.

3.78 0.28 −6.90%

Follow AQST

Alert me

Market cap: $509.6M
P/E: 0.0×
Fwd P/E: −9.7×
Dividend yield: —
F-score: 2/9
Altman Z: −2.19
Beneish M: −1.91
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	4	2	2	2	+8 more TTM periods Free account
ROE Full definition →	121.12%	145.10%	178.61%	278.54%
ROA Full definition →	(69.29%)	(56.63%)	(63.99%)	(50.44%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(73.82%)	(67.38%)	(79.38%)	(53.05%)
Average Days of Receivables Full definition →	62.94	49.86	145.55	99.25
Free Cash Flow per Share Full definition →	(0.37)	(0.36)	(0.50)	(0.46)
Free Cash Flow Full definition →	(45.95)	(44.32)	(52.99)	(50.94)
Capital Expenditures Full definition →	(0.58)	(0.48)	(0.56)	(0.49)
Other line items
Cash ROIC Full definition →	(49.64%)	(43.54%)	(46.07%)	(32.89%)
Accounts Receivable Turnover Full definition →	5.11	5.81	3.55	4.04
Accounts Payable Turnover Full definition →	1.70	1.52	0.92	1.87
Inventory Turnover Full definition →	2.30	2.41	3.04	2.31
Average Days of Payables Full definition →	183.54	236.20	587.42	230.04
Days of Inventory on Hand Full definition →	150.81	160.25	121.35	166.93
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	29.38%	31.90%	38.59%	43.58%
Selling, General and Administrative Expense of Revenue Full definition →	135.17%	142.73%	179.25%	145.25%
Share Based Compensation of Revenue Full definition →	17.32%	16.62%	17.12%	19.93%
Interest Coverage Full definition →	(3.23)	(3.34)	(4.15)	(3.27)
Operating CF/Net income Full definition →	0.58	0.64	0.63	0.73
Depreciation/Fixed assets Full definition →	2.54	2.88	2.97	2.94
Capex/Depreciation Full definition →	(0.06)	(0.04)	(0.05)	(0.04)
Revenue per Share Full definition →	0.43	0.41	0.42	0.39
Operating CF per Share Full definition →	(0.36)	(0.36)	(0.49)	(0.46)
Capex per Share Full definition →	0.00	0.00	(0.01)	0.00
Capex to Sales Full definition →	0.01	0.01	0.01	0.01

Show all line items

Columns are period end dates

Stockrow Weekly